ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years
Yifan Fu
Matched on ORCID iD 0000-0003-1678-6338; OpenAlex author ID A5102841389. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 26
2024: 3 papers · 2025: 1 paper · 2026: 2 papers
Papers 6
- TRDMT1-mediated mRNA m5C methylation decreases chemotherapy sensitivity by activating homologous recombination-mediated DNA damage repair and IRS2 expression i… Co-author DOI 10.1016/j.canlet.2026.218725↗
- Integrated scRNA-Seq and functional profiling reveal CD52 as a driver of pancreatic ductal adenocarcinoma metastasis and immunosuppression. Co-author DOI 10.1038/s41389-026-00637-x↗
- SPP1+ Venous Endothelial Cells and CRABP2+ Tumor Cells Contribute to Favorable Body and Tail Pancreatic Ductal Adenocarcinoma Tumor Microenvironment. First author DOI 10.1002/mc.23936↗
- Multiomics integration reveals NETosis heterogeneity and TLR2 as a prognostic biomarker in pancreatic cancer. Co-author DOI 10.1038/s41698-024-00586-x↗
- Unbiasedly decoding the tumor microenvironment with single-cell multiomics analysis in pancreatic cancer. Co-author DOI 10.1186/s12943-024-02050-7↗
- CALB2 drives pancreatic cancer metastasis through inflammatory reprogramming of the tumor microenvironment. Co-author DOI 10.1186/s13046-024-03201-w↗
Closest collaborators
The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jinxin Tao · 5 shared papers, 2024–2026 · strength 0.99
- Paper Integrated scRNA-Seq and functional profiling reveal CD52 as a driver of pancreatic ductal adenocarcinoma metastasis an… DOI 10.1038/s41389-026-00637-x↗
- Paper SPP1+ Venous Endothelial Cells and CRABP2+ Tumor Cells Contribute to Favorable Body and Tail Pancreatic Ductal Adenocar… DOI 10.1002/mc.23936↗
- Paper Multiomics integration reveals NETosis heterogeneity and TLR2 as a prognostic biomarker in pancreatic cancer. DOI 10.1038/s41698-024-00586-x↗
- Taiping Zhang · 5 shared papers, 2024–2026 · strength 0.99
- Paper Integrated scRNA-Seq and functional profiling reveal CD52 as a driver of pancreatic ductal adenocarcinoma metastasis an… DOI 10.1038/s41389-026-00637-x↗
- Paper SPP1+ Venous Endothelial Cells and CRABP2+ Tumor Cells Contribute to Favorable Body and Tail Pancreatic Ductal Adenocar… DOI 10.1002/mc.23936↗
- Paper Multiomics integration reveals NETosis heterogeneity and TLR2 as a prognostic biomarker in pancreatic cancer. DOI 10.1038/s41698-024-00586-x↗
- Wenhao Luo · 4 shared papers, 2024–2026 · strength 0.78
- Paper TRDMT1-mediated mRNA m5C methylation decreases chemotherapy sensitivity by activating homologous recombination-mediated… DOI 10.1016/j.canlet.2026.218725↗
- Paper SPP1+ Venous Endothelial Cells and CRABP2+ Tumor Cells Contribute to Favorable Body and Tail Pancreatic Ductal Adenocar… DOI 10.1002/mc.23936↗
- Paper Unbiasedly decoding the tumor microenvironment with single-cell multiomics analysis in pancreatic cancer. DOI 10.1186/s12943-024-02050-7↗
- Tao Liu · 4 shared papers, 2024–2025 · strength 0.74
- Paper SPP1+ Venous Endothelial Cells and CRABP2+ Tumor Cells Contribute to Favorable Body and Tail Pancreatic Ductal Adenocar… DOI 10.1002/mc.23936↗
- Paper Multiomics integration reveals NETosis heterogeneity and TLR2 as a prognostic biomarker in pancreatic cancer. DOI 10.1038/s41698-024-00586-x↗
- Paper Unbiasedly decoding the tumor microenvironment with single-cell multiomics analysis in pancreatic cancer. DOI 10.1186/s12943-024-02050-7↗
- Jianchun Xiao · 3 shared papers, 2024–2026 · strength 0.59
- Paper TRDMT1-mediated mRNA m5C methylation decreases chemotherapy sensitivity by activating homologous recombination-mediated… DOI 10.1016/j.canlet.2026.218725↗
- Paper SPP1+ Venous Endothelial Cells and CRABP2+ Tumor Cells Contribute to Favorable Body and Tail Pancreatic Ductal Adenocar… DOI 10.1002/mc.23936↗
- Paper CALB2 drives pancreatic cancer metastasis through inflammatory reprogramming of the tumor microenvironment. DOI 10.1186/s13046-024-03201-w↗
- Jiangdong Qiu · 3 shared papers, 2024–2025 · strength 0.55
- Paper SPP1+ Venous Endothelial Cells and CRABP2+ Tumor Cells Contribute to Favorable Body and Tail Pancreatic Ductal Adenocar… DOI 10.1002/mc.23936↗
- Paper Multiomics integration reveals NETosis heterogeneity and TLR2 as a prognostic biomarker in pancreatic cancer. DOI 10.1038/s41698-024-00586-x↗
- Paper CALB2 drives pancreatic cancer metastasis through inflammatory reprogramming of the tumor microenvironment. DOI 10.1186/s13046-024-03201-w↗
- Yupei Zhao · 3 shared papers, 2024 · strength 0.55
- Paper Multiomics integration reveals NETosis heterogeneity and TLR2 as a prognostic biomarker in pancreatic cancer. DOI 10.1038/s41698-024-00586-x↗
- Paper Unbiasedly decoding the tumor microenvironment with single-cell multiomics analysis in pancreatic cancer. DOI 10.1186/s12943-024-02050-7↗
- Paper CALB2 drives pancreatic cancer metastasis through inflammatory reprogramming of the tumor microenvironment. DOI 10.1186/s13046-024-03201-w↗
- Yuanyang Wang · 2 shared papers, 2026 · strength 0.49
- Paper Integrated scRNA-Seq and functional profiling reveal CD52 as a driver of pancreatic ductal adenocarcinoma metastasis an… DOI 10.1038/s41389-026-00637-x↗
- Paper TRDMT1-mediated mRNA m5C methylation decreases chemotherapy sensitivity by activating homologous recombination-mediated… DOI 10.1016/j.canlet.2026.218725↗
- Zhe Cao · 2 shared papers, 2025–2026 · strength 0.43
- Paper TRDMT1-mediated mRNA m5C methylation decreases chemotherapy sensitivity by activating homologous recombination-mediated… DOI 10.1016/j.canlet.2026.218725↗
- Paper SPP1+ Venous Endothelial Cells and CRABP2+ Tumor Cells Contribute to Favorable Body and Tail Pancreatic Ductal Adenocar… DOI 10.1002/mc.23936↗
- Yueze Liu · 2 shared papers, 2025–2026 · strength 0.43
- Paper TRDMT1-mediated mRNA m5C methylation decreases chemotherapy sensitivity by activating homologous recombination-mediated… DOI 10.1016/j.canlet.2026.218725↗
- Paper SPP1+ Venous Endothelial Cells and CRABP2+ Tumor Cells Contribute to Favorable Body and Tail Pancreatic Ductal Adenocar… DOI 10.1002/mc.23936↗
- Zhe Cao · 2 shared papers, 2024–2026 · strength 0.41
- Paper Integrated scRNA-Seq and functional profiling reveal CD52 as a driver of pancreatic ductal adenocarcinoma metastasis an… DOI 10.1038/s41389-026-00637-x↗
- Paper CALB2 drives pancreatic cancer metastasis through inflammatory reprogramming of the tumor microenvironment. DOI 10.1186/s13046-024-03201-w↗
- Lei You · 2 shared papers, 2024–2026 · strength 0.39
- Paper TRDMT1-mediated mRNA m5C methylation decreases chemotherapy sensitivity by activating homologous recombination-mediated… DOI 10.1016/j.canlet.2026.218725↗
- Paper CALB2 drives pancreatic cancer metastasis through inflammatory reprogramming of the tumor microenvironment. DOI 10.1186/s13046-024-03201-w↗
- Hua Huang · 2 shared papers, 2024–2025 · strength 0.35
- Zeyu Zhang · 1 shared paper, 2026 · strength 0.25
- Yupei Zhao · 1 shared paper, 2026 · strength 0.24
- Hao Chen · 1 shared paper, 2025 · strength 0.20
- Yuanyang Wang · 1 shared paper, 2025 · strength 0.20
- Jun Wang · 1 shared paper, 2025 · strength 0.20
- Ruobing Wang · 1 shared paper, 2024 · strength 0.20
- Jiangdong Qiu · 1 shared paper, 2024 · strength 0.20
- Dan Su · 1 shared paper, 2024 · strength 0.20
- Wenhao Luo · 1 shared paper, 2024 · strength 0.20
- Bo Ren · 1 shared paper, 2024 · strength 0.16
- Gang Yang · 1 shared paper, 2024 · strength 0.16
- Dan Su · 1 shared paper, 2024 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.